Biophytis S.A. (BPTSY)
OTCMKTS · Delayed Price · Currency is USD
2.000
0.00 (0.00%)
Oct 15, 2025, 8:00 PM EDT
Biophytis Market Cap
Biophytis has a market cap or net worth of $3.74 million as of October 17, 2025. Its market cap has increased by 88.82% in one year.
Market Cap
3.74M
Enterprise Value
15.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.00
Market Cap Chart
Since July 13, 2015, Biophytis's market cap has decreased from 49.80M to 3.74M, a decrease of -92.49%. That is a compound annual growth rate of -22.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 3.74M | 29.72% |
| Dec 31, 2024 | 2.88M | -28.25% |
| Dec 29, 2023 | 4.02M | -50.09% |
| Dec 30, 2022 | 8.05M | -88.62% |
| Dec 31, 2021 | 70.76M | -37.02% |
| Dec 31, 2020 | 112.35M | 3,661.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 749.94M |
| Elite Pharmaceuticals | 652.54M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| CytoDyn | 365.33M |
| Northwest Biotherapeutics | 360.44M |
| Silence Therapeutics | 301.35M |
| American Oncology Network | 291.58M |